Brigit Biofarmaka Teknologi Tbk. vs Wijaya Karya Beton Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Wijaya Karya Beton Tbk. trades at Rp76 (market cap 653.66B, 1.96M 24h volume). The key difference: Wijaya Karya Beton Tbk. is far larger — about 3.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Wijaya Karya Beton Tbk. is more actively traded (1.96M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WTON | |
|---|---|---|
Market Cap | 172.82B | 653.66B |
Volume | 592.2K | 1.96M |
Lot | 5.92K | 19.63K |
Turnover | 147.05M | 148M |
Average Price | 248.31 | 75.39 |
Value | 147.05M | 148M |
Indicative Equilibrium Price | 254 | 76 |
Indicative Equilibrium Volume | 10 | 26 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Wijaya Karya Beton (the Company), to hereafter with Wika Beton, was esthablished in Jakarta with the deed of a limited liability company PT Wijaya Karya Beton No 44 dated March 11, 1997 (Act No 44), made in the presence of Achmad Bajuri, SH, as successor of the Imas Fatimah, SH, notary in Jakarta PT Wijaya Karya Beton operational activities started since March 11, 1997
Read more on WTON →